HERC and COVID-19
Despite the practical challenges we are all facing, several members of the HERC team have been able to use their skills and experience to contribute to the scientific evidence base on COVID-19.
Koen Pouwels is part of the team that is delivering a study tracking COVID-19 infection and immunity levels in up to 300,000 people in the UK, which started in April.
Koen has also co-authored a recent paper on improving COVID-19 surveillance in long-term care.
A second paper, on understanding the heterogeneity of adverse COVID-19 outcomes, has recently been published by Francesco Salustri and colleagues.
Apostolos Tsiachristas is involved in a number of COVID studies.
Apo is part of a team that has been awarded funding from Hampshire Sustainability and Transformation Partnership to investigate the impact of COVID-19 on patients with type 2 diabetes.
He is also involved in the Better Outcomes For Everyone trial, where he will be looking at COVID-19-related complications in patients with asthma and COPD in Italy.
In addition, he is investigating the impact of COVID-19 on self-harm and suicide as part of the Multicentre Study for Self-Harm In England, and is working on a study funded by the University of Oxford COVID-19 Research Response Fund on supporting hospital and paramedic employees during COVID-19.
Away from formal scientific studies and outputs, Rositsa Koleva-Kolarova has blogged for Health Economics, Policy and Law on Bulgaria’s response to the COVID-19 pandemic, and a lockdown exit strategy suggested by Philip Clarke and Laurence Roope was recently featured in a Financial Times article and a BMJ blog post.